0001209191-20-025177.txt : 20200420 0001209191-20-025177.hdr.sgml : 20200420 20200420202017 ACCESSION NUMBER: 0001209191-20-025177 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200417 FILED AS OF DATE: 20200420 DATE AS OF CHANGE: 20200420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pang Phillip CENTRAL INDEX KEY: 0001787370 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 20803728 MAIL ADDRESS: STREET 1: C/O VIR BIOTECHNOLOGY, INC. STREET 2: 499 ILLINOIS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-17 0 0001706431 Vir Biotechnology, Inc. VIR 0001787370 Pang Phillip C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158 0 1 0 0 Chief Medical Officer Common Stock 2020-04-17 4 M 0 8000 0.855 A 15777 D Employee Stock Option (Right to Buy) 0.855 2020-04-17 4 M 0 8000 0.00 D 2027-03-09 Common Stock 8000 95333 D 1/4 of the 111,111 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. The aggregate number of shares subject to the stock option has been reduced by one share to 111,110 shares due to rounding in connection with a partial exercise of the stock option and a reverse stock split effected prior to the Issuer's initial public offering. /s/ Howard Horn, Attorney-in-Fact 2020-04-20